“ Our assays can help to identify individuals who have been exposed to SARS-CoV-2 and may play a critical role in accurate evaluation of antibody status before and after infection, in antibody therapies or vaccination programs.”
COVEL COVID-19 (SARS-CoV-2) QUANTITATIVE IgG ELISA TEST
COVEL COVID-19 (SARS-CoV-2) QUANTITATIVE IgG ELISA TEST is an enzyme-linked immunosorbent assay (ELISA)-based serologic test to detect SARS-CoV-2 antibodies in serum or plasma components of blood.
The detection of anti-SARS-CoV-2 IgG antibodies for pathogen contact confirmation requires a high specificity of the serological test system. False-positive results suggest a possible immunity, which harms the individual and the social level (spread of the pandemic).
COVEL COVID-19 (SARS-CoV-2) QUANTITATIVE IgG ELISA TEST is a highly sensitive and specific diagnostic kit intended for high-throughput, gold standard antibody screening for patients suspected of COVID-19 infection and patients treated with antibody therapies or vaccination.